Total Med Solutions

Total Med Solutions operates a comprehensive medical wellness and aesthetics practice in Dallas, TX, combining peptide therapy with regenerative treatments for weight management, joint health, and aesthetic enhancement. The clinic has built a substantial patient base across the Dallas-Fort Worth metroplex, reflected in over 1,200 patient reviews, by focusing on evidence-based protocols that address metabolic dysfunction, musculoskeletal concerns, and age-related aesthetic changes through medical-grade interventions.

The peptide therapy program at Total Med Solutions centers on three primary compounds selected for their distinct mechanisms of action. Semaglutide and Tirzepatide represent the clinic's GLP-1 receptor agonist offerings for patients addressing obesity and metabolic syndrome, with protocols designed around weekly subcutaneous administration and structured nutritional guidance. AOD-9604, a modified fragment of human growth hormone, is incorporated into treatment plans for patients seeking fat metabolism support without the systemic effects of full growth hormone therapy. These peptides are prescribed following comprehensive metabolic assessment, including body composition analysis and laboratory evaluation of thyroid function, insulin sensitivity, and lipid panels. The clinic structures peptide protocols with defined titration schedules, monitoring intervals, and specific outcome metrics rather than open-ended prescribing.

Total Med Solutions employs medical providers credentialed in aesthetic medicine and functional wellness who conduct in-person consultations at the Dallas location. The clinical team performs initial evaluations that include medical history review, contraindication screening, and discussion of realistic timelines for peptide therapy outcomes. For weight loss patients, the approach combines peptide prescriptions with dietary modification strategies and optional adjunctive treatments such as lipotropic injections. Joint pain patients may receive peptide therapy alongside regenerative injection techniques. Hair restoration services utilize both peptide-based protocols and direct scalp treatments, addressing androgenic alopecia and diffuse thinning patterns through multi-modal intervention. The clinic maintains an in-person model requiring patients to visit the Dallas facility for initial assessment and periodic follow-up, with treatment plans documented through electronic health records.

Patients beginning peptide therapy at Total Med Solutions undergo a structured onboarding process that includes injection technique training for self-administration, side effect education specific to each compound, and establishment of monitoring schedules. Semaglutide and Tirzepatide patients receive guidance on managing gastrointestinal adaptation during dose escalation, with protocols for adjusting titration speed based on individual tolerance. The clinic provides specific parameters for when to contact medical staff regarding adverse effects versus expected adjustment symptoms. Follow-up visits are scheduled at defined intervals—typically every 4-6 weeks during active weight loss phases—to assess progress through objective measures including weight, body composition changes, and patient-reported outcomes. The aesthetic and wellness services extend beyond peptides to include injectable treatments for facial rejuvenation and body contouring, allowing patients to address multiple concerns within a single practice.

Total Med Solutions differentiates itself in the Dallas medical wellness market through its integration of peptide therapy with complementary aesthetic and regenerative services under one clinical roof. Patients seeking weight management can access not only GLP-1 medications but also body contouring treatments as they progress toward goals. Those addressing joint pain can combine peptide protocols with injection-based therapies targeting specific anatomical sites. The clinic's substantial review volume indicates an established operational infrastructure for managing high patient volume while maintaining individualized treatment planning. The in-person consultation model ensures direct provider assessment before peptide initiation, with Dallas-area residents able to access the full spectrum of services without coordinating care across multiple facilities. This integrated approach allows for treatment plan adjustments based on real-time clinical assessment rather than remote-only management.